Shares of DRI Healthcare Trust (TSE:DHT.UN – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six ratings firms that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is C$17.94.
Several research firms have recently weighed in on DHT.UN. Scotiabank boosted their price objective on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Raymond James dropped their price objective on DRI Healthcare Trust from C$23.00 to C$22.00 in a research note on Wednesday, November 13th. Finally, CIBC cut their price objective on DRI Healthcare Trust from C$19.50 to C$18.00 and set an “outperform” rating for the company in a research report on Thursday, December 12th.
Check Out Our Latest Analysis on DHT.UN
DRI Healthcare Trust Stock Performance
DRI Healthcare Trust Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, October 18th. Investors of record on Friday, October 18th were paid a $0.085 dividend. The ex-dividend date was Friday, September 27th. This represents a $0.34 annualized dividend and a yield of 2.88%. DRI Healthcare Trust’s dividend payout ratio (DPR) is presently -920.00%.
About DRI Healthcare Trust
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
Read More
- Five stocks we like better than DRI Healthcare Trust
- Trading Stocks: RSI and Why it’s Useful
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What Does a Stock Split Mean?
- 2 Drone Stocks Surging from Increased Media Attention
- Investing in Travel Stocks Benefits
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.